Colgate-Palmolive (NYSE:CL) Shares Bought by Emerald Advisors LLC

Emerald Advisors LLC lifted its stake in Colgate-Palmolive (NYSE:CL) by 3.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,689 shares of the company’s stock after purchasing an additional 132 shares during the quarter. Emerald Advisors LLC’s holdings in Colgate-Palmolive were worth $291,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of CL. Falcon Wealth Planning acquired a new stake in Colgate-Palmolive during the 1st quarter valued at $579,000. Marshall Financial Group LLC grew its holdings in shares of Colgate-Palmolive by 4.7% during the first quarter. Marshall Financial Group LLC now owns 13,949 shares of the company’s stock valued at $1,100,000 after buying an additional 624 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lifted its stake in Colgate-Palmolive by 299.9% in the 1st quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 79,016 shares of the company’s stock worth $6,229,000 after acquiring an additional 59,255 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its position in Colgate-Palmolive by 7.9% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 71,082 shares of the company’s stock worth $5,603,000 after acquiring an additional 5,188 shares during the period. Finally, Exchange Traded Concepts LLC grew its stake in Colgate-Palmolive by 16.9% during the 1st quarter. Exchange Traded Concepts LLC now owns 126,671 shares of the company’s stock valued at $9,985,000 after acquiring an additional 18,292 shares in the last quarter. 76.47% of the stock is owned by institutional investors.

In other news, insider Jennifer Daniels sold 20,692 shares of the business’s stock in a transaction that occurred on Thursday, February 4th. The stock was sold at an average price of $78.65, for a total transaction of $1,627,425.80. Following the sale, the insider now directly owns 55,585 shares in the company, valued at $4,371,760.25. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Philip G. Shotts sold 346 shares of the company’s stock in a transaction on Tuesday, February 16th. The shares were sold at an average price of $77.16, for a total value of $26,697.36. Following the completion of the transaction, the vice president now owns 41,128 shares of the company’s stock, valued at $3,173,436.48. The disclosure for this sale can be found here. Insiders sold a total of 30,810 shares of company stock worth $2,418,650 over the last 90 days. Company insiders own 0.78% of the company’s stock.

CL has been the topic of several research reports. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 price objective on the stock. in a research note on Thursday, January 28th. Sanford C. Bernstein assumed coverage on shares of Colgate-Palmolive in a research note on Tuesday, January 19th. They issued an “underperform” rating and a $77.00 price target on the stock. JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $87.00 to $85.00 and set a “neutral” rating on the stock in a research note on Thursday. Credit Suisse Group upgraded Colgate-Palmolive from an “underperform” rating to a “neutral” rating and lifted their price target for the company from $70.00 to $80.00 in a report on Monday, February 1st. Finally, Berenberg Bank raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $76.00 price objective on the stock in a research report on Tuesday, January 26th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $82.17.

Shares of NYSE CL traded down $0.24 during trading hours on Thursday, hitting $80.91. 120,226 shares of the company’s stock were exchanged, compared to its average volume of 4,941,420. The company’s 50-day moving average price is $77.81 and its 200-day moving average price is $80.65. Colgate-Palmolive has a 1-year low of $65.54 and a 1-year high of $86.41. The stock has a market capitalization of $68.57 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 3.83 and a beta of 0.59. The company has a debt-to-equity ratio of 6.50, a current ratio of 0.97 and a quick ratio of 0.62.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Thursday, January 28th. The company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.01. The company had revenue of $4.32 billion during the quarter, compared to analyst estimates of $4.15 billion. Colgate-Palmolive had a return on equity of 383.88% and a net margin of 16.65%. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.73 earnings per share. On average, research analysts expect that Colgate-Palmolive will post 3.05 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, May 14th. Investors of record on Wednesday, April 21st will be paid a dividend of $0.45 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend is Tuesday, April 20th. Colgate-Palmolive’s dividend payout ratio is presently 62.19%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Further Reading: Dual Listing What You Need to Know

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.